Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
2.
Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.
Blood
; 131(1): 108-120, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051183
3.
The equine CD1 gene family is the largest and most diverse yet identified.
Immunogenetics
; 66(1): 33-42, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24196432
4.
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
J Clin Invest
; 130(10): 5127-5141, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831296
5.
In contrast to other species, α-Galactosylceramide (α-GalCer) is not an immunostimulatory NKT cell agonist in horses.
Dev Comp Immunol
; 49(1): 49-58, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445911